Table 2 Deterministic results for ICER of placebo, 9H, 4R, 3HR and 3HP compared with 6H.

From: Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis

Regimen

Incremental risk

(adverse events)

Incremental benefit

(TB prevention)

IRBR

6H

Reference

Reference

Reference

Placebo

 − 0.0001

 − 0.0128

0.004

9H

 − 0.0378

0.0034

 − 11.040

4R

 − 0.0440

0.0056

 − 7.905

3HR

 − 0.0007

0.0071

 − 0.097

3HP

 − 0.0453

0.0049

 − 9.245